Myriad Genetics Announces Second Quarter Fiscal 2005 Financial Results Conference Call

Tuesday, February 8 at 10:00 a.m. ET

SALT LAKE CITY, Jan. 28 /PRNewswire-FirstCall/ -- Myriad Genetics, Inc. (Nasdaq: MYGN) has arranged a conference call with the management team to provide a company update.

Peter Meldrum, President and Chief Executive Officer will host the call along with Jay Moyes, Chief Financial Officer, and Adrian Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.

                            DATE: February 8, 2005
                              TIME: 10:00 am ET
                       DOMESTIC DIAL-IN: (877) 707-9631
                    INTERNATIONAL DIAL-IN: (785) 832-1508
    (Please dial in approximately 10 minutes before the call is scheduled
                                  to begin)

        A press release will be issued at 6:30 am ET on February 8th.
  Replay of the call will be available from two hours after the call through
          February 15th by dialing (800) 934-3942 or (402) 220-1162.

          A live audio Webcast will be available at: www.myriad.com

This call is being webcast by Thomson/CCBN and is also being distributed though the Thomson/StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.fulldisclosure.com, Thomson/CCBN's individual investor portal. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).

SOURCE Myriad Genetics, Inc.
01/28/2005
CONTACT: Suzanne Barton of Myriad Genetics, +1-801-584-1138
/Web site: http://www.streetevents.com / /Web site: http://www.fulldisclosure.com / /Web site: http://www.myriad.com /